OTC Nasal Spray Seemed To Cut COVID Infections By 67% In Mid Sized Trial

OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial

via jamanetwork.com

Short excerpt below. Read at the original source.

Daily squirts of a safe, over-the-counter allergy nasal spray may prevent COVID-19 infections from taking hold, according to results published Tuesday in JAMA Internal Medicine. In a mid-staged trial, the spray appeared to reduce infections by promising 67 percent, though a larger trial will need to confirm that robust efficacy. The trial was a randomized, […]

Read at Source